Jaguar Health, Inc. (JAGX)
4.79
+0.26
(+5.74%)
USD |
NASDAQ |
Oct 09, 16:00
4.85
+0.06
(+1.25%)
After-Hours: 20:00
Jaguar Health Net Income (Quarterly) : -12.80M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.80M |
| March 31, 2026 | 8.723M |
| December 31, 2025 | -23.19M |
| September 30, 2025 | -9.648M |
| June 30, 2025 | -10.56M |
| March 31, 2025 | -10.60M |
| December 31, 2024 | -10.23M |
| September 30, 2024 | -10.02M |
| June 30, 2024 | -9.628M |
| March 31, 2024 | -9.368M |
| December 31, 2023 | -9.309M |
| September 30, 2023 | -7.904M |
| June 30, 2023 | -12.29M |
| March 31, 2023 | -12.40M |
| December 31, 2022 | -8.232M |
| September 30, 2022 | -12.61M |
| June 30, 2022 | -9.39M |
| March 31, 2022 | -18.16M |
| December 31, 2021 | -14.32M |
| September 30, 2021 | -12.19M |
| June 30, 2021 | -14.08M |
| March 31, 2021 | -12.01M |
| December 31, 2020 | -8.769M |
| September 30, 2020 | -7.866M |
| Date | Value |
|---|---|
| June 30, 2020 | -9.238M |
| March 31, 2020 | -7.936M |
| December 31, 2019 | -5.959M |
| September 30, 2019 | -7.555M |
| June 30, 2019 | -16.72M |
| March 31, 2019 | -8.304M |
| December 31, 2018 | -12.65M |
| September 30, 2018 | -6.138M |
| June 30, 2018 | -7.657M |
| March 31, 2018 | -5.697M |
| December 31, 2017 | -20.21M |
| September 30, 2017 | 4.760M |
| June 30, 2017 | -1.806M |
| March 31, 2017 | -4.715M |
| December 31, 2016 | -3.677M |
| September 30, 2016 | -3.416M |
| June 30, 2016 | -3.658M |
| March 31, 2016 | -3.984M |
| December 31, 2015 | -4.131M |
| September 30, 2015 | -2.961M |
| June 30, 2015 | -5.263M |
| March 31, 2015 | -3.937M |
| June 30, 2014 | -1.944M |
| March 31, 2014 | -1.966M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Omeros Corp. | 6.637M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.225M |
| Total Expenses (Quarterly) | 13.91M |
| EPS Diluted (Quarterly) | -235.46 |
| Enterprise Value | 11.57M |
| Gross Profit Margin (Quarterly) | -22.04% |
| Profit Margin (Quarterly) | -1.05K% |
| Earnings Yield | -114.5K% |
| Normalized Earnings Yield | -98306.01 |